Level 1 · RCT / systematic review of RCTs
UHMS-approved
Cochrane
ENT
Bottom line
Supports early (<14 day) HBOT referral for idiopathic SSNHL per UHMS 2019 approval.
Outcome
Significant improvement in pure-tone average when HBOT delivered within 2 weeks of onset.
Conditions studied
- Sudden Sensorineural Hearing Loss (SSNHL) — Moderate — UHMS approved
Full citation
Bennett MH, Kertesz T, Perleth M, Yeung P, Lehm JP. Hyperbaric Oxygen for Idiopathic Sudden Sensorineural Hearing Loss and Tinnitus. Cochrane Database of Systematic Reviews. 2012. doi:10.1002/14651858.CD004739.pub4.
View on PubMed (PMID 23076895) →
Related studies
- Hyperbaric Oxygen Therapy Indications, 15th Edition (UHMS) (2023, Level 5)